NCT06054165 Impact of a Clinical Pathway for Pelvic Fragility Fractures
| NCT ID | NCT06054165 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Condition | Pelvic Bone Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 393 participants |
| Start Date | 2024-01-21 |
| Primary Completion | 2025-04-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 393 participants in total. It began in 2024-01-21 with a primary completion date of 2025-04-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.
Eligibility Criteria
Inclusion Criteria: * Pelvic fragility fracture caused by low energetic trauma * Patients presented at the emergency room or out-patient clinic of a participating hospital Exclusion Criteria: * Patients with high suspicion of a pelvic fracture due to a malignant tumor * Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease) * Patients who pre-trauma received palliative or terminal care * Patients who pre-trauma were wheelchair bound or bedridden * Patients who suffer from complications from previous pelvic ring fixation * Patients with insufficient comprehension of the Dutch language to be able to carry out the physiotherapy instructions for early mobilization
Contact & Investigator
Frank W Bloemers, prof
PRINCIPAL INVESTIGATOR
Amsterdam UMC
Frequently Asked Questions
Who can join the NCT06054165 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Pelvic Bone Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06054165 currently recruiting?
Yes, NCT06054165 is actively recruiting participants. Contact the research team at d.vanembden@amsterdamumc.nl for enrollment information.
Where is the NCT06054165 trial being conducted?
This trial is being conducted at Almere Stad, Netherlands, Alkmaar, Netherlands, Amsterdam, Netherlands, Amsterdam, Netherlands and 4 additional locations.
Who is sponsoring the NCT06054165 clinical trial?
NCT06054165 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The principal investigator is Frank W Bloemers, prof at Amsterdam UMC. The trial plans to enroll 393 participants.